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Hemolytic activityAbstract The present study reports a convenient approach for the synthesis of thiophene sulfon-
amide derivatives (3a–3k) via Suzuki cross coupling reaction. This method of synthesis involved the
reactions of various aryl boronic acids and esters with 5-bromthiophene-2-sulfonamide (2) under
mild and suitable temperature conditions. The compounds synthesized in the present study were
subjected to urease inhibition and hemolytic activities. The substitution pattern and the electronic
effects of different functional groups (i.e., Cl, CH3, OCH3, F etc.) available on the aromatic ring are
found to have signiﬁcant effect on the overall results. The compound 5-Phenylthiophene-2-sulfon-
amide 3a showed the highest urease inhibition activity with IC50 value  30.8 lg/mL compared with
the thiourea (used as standard) having IC50 value  43 lg/mL. Moreover, almost all of the com-
pounds were examined for the hemolytic activity against triton X-100 with positive results obtained
S404 M. Noreen et al.in most of the cases. In addition, the antibacterial activities of the derivatives of 5-arylthiophene-2-
sulfonamide and 5-bromothiophene-2-acetamide were also investigated during the course of the
study.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Suzuki cross coupling reaction has a great deal of impor-
tance in the synthesis of substituted aromatic compounds of
biological importance. The relatively easy formation of C-C
bonds via Suzuki cross coupling reaction may have its origin
in the high tolerance of functional group through this reaction
pathway [13]. Many heterocycles such as arylated furans and
thiophenes have been synthesized in high yield using this reac-
tion scheme [14]. The major interests in the developments of
thiophenes are due to their wide range of device applications
such as light emitting devices, dye sensitized organic solar cells,
and organic TFT’s and many others [2]. Some of the important
characteristics that make thiophenes and thiophenes based
polymers an important class of chemical compounds are their
high electrical conductivity [Poly(3,4-ethylenedioxythiophene)
or PEDOT is a conducting polymer], liquid crystalline charac-
teristics and interesting light responsive characteristics [19]. In
view of these interesting characteristics of thiophene, it is
highly desirable to synthesize thiophene with different func-
tional groups, and one such facile way to synthesize thiophene
derivatives is via palladium catalyzed Suzuki cross coupling
reactions. Being versatile in nature and demonstrating compat-
ibility with functional groups, the Suzuki cross coupling reac-
tion is the method of choice for reactions involving CAC bond
formation [17].
Among the wide range of pharmaceutical compounds, the
sulfonamide functional groups are found to play a key role
in designing the drugs [3]. Sulfonamides represent an impor-
tant class of biologically productive molecules, which exhibit
broad diversity of biological activities [12]. Some of their
important applications include the treatment of many micro-
bial infections by inhibiting the growth of gram negative and
gram positive bacteria [24]. Signiﬁcant biological activities
have been shown by compounds bearing sulfonamide moieties,
which make them important in drug discovery [10]. Sulfona-
mides usually get attached to the Dihydropteroate (DHPS)
enzyme, which then catalyzes the bacterial pathways in folic
acid and few eukaryotic cells [6]. In the case of human cells,
mechanism does not obey [1]. Thiophene-2-sulfonamides are
also known as carbonic anhydrase inhibitors and the literature
suggests that many of its simple derivatives also show diuretic
activity [5]. The barbituric and thiobarbituric acid based sul-
fonamides contain coordinating sites to nickel (II) urease sites.
Earlier, it was reported that the electronic effects and presence
of different functional groups on aromatic rings can affect the
urease inhibitory activity. Electronic and Steric factors also
showed great inﬂuence on the biological activities [27]. Jahan
and coworkers reported that the compounds having halogen
functional groups exhibit the highest hemolytic activity [16].
In routine, the sulfonamides are prepared by the reaction of
a sulfonyl chloride with ammonia or with primary or second-
ary amines [20], but this methodology has some limitationsand drawbacks. As an example, sulfonyl chlorides are not suit-
able for long term storage and due to their instability, handling
of sulfonyl chlorides is rather difﬁcult [8]. A rather convenient
route to synthesize sulfonamides is via intermolecular free rad-
ical reactions of pentaﬂuorophenylvinyl sulfonate with subse-
quent aminolysis reaction [7].
In order to explore an yet easy and facile method to synthe-
size thiophene based derivates, the aim of the present study is
to synthesize different derivatives of 5-bromothiophene-2-sul-
fonamide via Suzuki cross coupling reactions using different
aryl boronic acids and aryl boronic esters with 5-bromothio-
phene-2-sulfonamide. The results from the present study
revealed that the 5-bromothiophene-2-sulfonamide has been
found active against many diseases. In view of this ﬁnding,
we investigated the anti-urease, antibacterial and hemolytic
or cytotoxicity activities of these derivatives. To the best of
our knowledge, this work has not been reported elsewhere so
far.
2. Experimental
2.1. General
For synthesis, analytical grade reagents and chemicals were
purchased from Sigma Aldrich and Alfa Aesar. The Buchi
melting point B-540 apparatus was used to record melting
points. The Proton 1H-NMR and Carbon 13, 13C-NMR spec-
tra were obtained in CDCl3 or CD3OD on the Bruker Aspect
AM-400 NMR. The chemical shift values were recorded in
Delta (d) ppm, whereas the coupling constant was obtained
and recorded in the units of Hertz (Hz). JMS-HX-110 spectro-
photometer with a data system was used to record EI-MS spec-
tra. Column chromatography technique was used to purify
compounds. For column chromatography, silica gels of mesh
size 230–400 and 70–230 were used. Moreover, the Merck sil-
ica gel 60PF254 TLC cards were used to monitor the reaction
and newly synthesized compounds were detected/visualized
by UV lamp (254–365).2.2. Synthesis of 5-bromothiophene-2-sulfonamide (2)
For the synthesis of 2 from 1, to a solution of 40–60 mmol of
freshly distilled chlorosulfonic acid in 6.00 mL of CCl4,
12 mmol of bromothiophene was added drop wise with vigor-
ous stirring and subsequent cooling up to 30 C. Stirring was
done at 25 C for another 30 min and then at room temper-
ature for 30 min. After this, the solution was poured onto the
crushed ice. In this way, the organic layer got separated, and
the solvent was removed under reduced pressure. Later on,
about 50 ml of 25% ammonia solution was mixed with the res-
idue and was kept for 3 h and neutralized with 10% HCl. The
ﬁnal product (5-bromothiophene-2-sulfonamide precipitates)
Synthesis of thiophene sulfonamide derivatives via Suzuki cross coupling reactions S405was ﬁltered, dried and later compared with the previously
reported compound [31].
2.3. Preparation of 5-bromothiophene-2-sulfonyl acetamide (4)
A mixture of 5-bromothiophene-2-sulfonamide (2 mol) and
acetic anhydride (3.1 mol) in acetonitrile (5.00 mL) was treated
with few drops of concentrated sulfuric acid under nitrogen
atmosphere. The reaction mixture was stirred for 40 min at
60 C and then 15–20 mL distilled water was added to this
mixture with continuous stirring to form precipitates. Further
stirring was carried out for 1 h at room temperature. The solu-
tion containing precipitates was then ﬁltered and the obtained
precipitates were subsequently washed with water and dried
later. Further puriﬁcation and identiﬁcation of the ﬁnal prod-
uct were done by ﬂash chromatography and spectroscopic
techniques, respectively [21].
2.4. General procedure for the synthesis of 5-arylthiophene-2-
sulfonamide (3a–k)
In a 0.704 mmol solution of 5-bromothiophene-2-sulfonamide
about 5 mol%Pd(PPh3)4 was added in dioxane (4.00 mL) under
nitrogen atmosphere. The reaction mixture was then stirred for
30 min at room temperature. After facile mixing, the aryl boro-
nic acids, aryl boronic esters (0.774 mmol) and potassium phos-
phate (1.409 mmol) were added with the addition of 1.00 mL
water (solvent/H2O 4:1) under nitrogen atmosphere. The solu-
tion was stirred at 95 C for 30 h and then subsequently cooled
to room temperature. Extraction was carried out with ethyl-ace-
tate to obtain the organic layer that was later ﬁltered and dried
by the addition ofMgSO4. The solvent was then removed under
reduced pressure. The residue obtained was puriﬁed by column
chromatography using ethyl-acetate and n-hexanewith the 50%
ratio to obtain the desired product. The ﬁnal product was char-
acterized by spectroscopic techniques.
2.5. Hemolytic activity
The cytotoxicity studies of newly synthesized derivatives of 5-
bromothiophene-2-sulfonamide were carried out by the use of
hemolytic activity according to the method reported by [29].
The solutions of the compounds under investigation were pre-
pared at a concentration of 1 mg/mL in 10% ethyl acetate sol-
vent. Heparinized three ml human fresh blood was
homogeneously mixed and spilled into 15.00 mL sterile falcon
tube and centrifuged for 5 min. Sterile isotonic phosphate buffer
saline chilled (4 C) solution (5.00 mL) with pH range 7.4 was
used to wash it for three times after removing supernatant.
Washed red blood cells were suspended in 20.00 mL chilled
PBS. Hemocytometer was used to count the erythrocytes.
7.068 · 108 red blood cells per mL count were maintained for
each essay. In 20 lL of compound 180 lL diluted blood cell
was added 180 lL and suspended in eppendrofs, and incubated
at 37 C for 35 min. After incubation, place the tubes in ice bath
for 5 min and again centrifuge for another 5 min. Once, the pro-
cess of centrifugation completed, the supernatant was collected
carefully, diluted with the addition of chilled 900 lL of PBS.
Later on, all eppendrofs were kept in ice bath and from each
eppendrof about 200 lL solution was added into 96 well plates.
TritonX-100 with the concentration of 0.1%was taken for eachessay as positive control, while phosphate buffer was taken as
negative control. Absorbance of the solutions was determined
at 576 nm with a micro plate reader [26].
2.6. Urease inhibition activity
25 lL of the enzyme Jack bean urease was added to the 55 lL
of 100 mM urea containing buffer solution in a conical ﬂask.
This mixture of solution was then incubated with (0.5 mM
conc.) 15 lL of newly synthesized compounds for 15 min at
30 C in 96-well plates. Anti-urease activity was examined by
using the Indophenol method (13) of determining the produc-
tion of ammonia. In each well, 45 lL of phenol reagent (0.005
% W/V sodium nitroprusside and 1% W/V phenol) and 70 lL
of alkali reagent (NaOH 0.5% W/V and 0.1% NaOCl) were
added. After 50 min, the increase in absorbance values of each
sample was measured at 630 nm by using a micro plate reader.
All reactions were repeated three times to obtain 200 lL of
the ﬁnal volume. Softmax pro software was used to record
the change in absorbance values. All assays were carried out
at the speciﬁc pH value 6.8. The % inhibition value was cal-
culated using the relation [100-(OD test well/OD con-
trol) · 100]. Thiourea was used as the standard urease
inhibitor [11]. EZ-ﬁt kinetic database was used to determine
IC50 values [25]. While, in the cases of colored compounds,
blank samples were also prepared. The absorbance value of
the blank sample was subtracted from the absorbance value
of the sample in order to obtain the corrected absorbance of
sample. These corrected values of absorbance for each sample
were used to calculate % age inhibition.2.7. Antibacterial assay
The antibacterial activities of newly synthesized compounds
(5-arylthiophene-2-sulfonamide and 5-bromothiophene-2-
acetamide) were determined by using the method described
by Patel et al. According to this method, an increase in the
growth of microbial cells results in an increase in the microbial
number [28]. In the present study, antibacterial activity of as-
synthesized compounds were determined against the bacterial
strains [such as Escherichia coli (Gram negative), Staphylococ-
cus aureus (Gram positive), Pseudomonas aeroginosa (Gram
negative), Bacillus subtilis (Gram positive), Shigellasonnei
(Gram negative) and Salmonella typhi (Gram negative)], which
were acquired from the Agha khan University in Karachi,
Pakistan. Streptomycin was used as positive control to com-
pare the sensitivity of the strains. The antibacterial activity
of all compounds under investigation was measured by the
96 well plate method optimized in our laboratory. In each well,
about 175 lL of sterilized broth was added and inoculated
with 5 lL glycerol stock of a speciﬁc bacterial strain. The ini-
tial absorbance reading was maintained strictly between 0.12–
0.19, and the bacteria were allowed to grow overnight in an
incubator. After a waiting time (12 h), about 20 lL of the
test sample was added to the pre-determined wells, (test con-
centration of sample was 20 lg/well) and the total volume of
each well was kept 200 lL. The plates were further incubated
for 16–24 h at 37 C. Elisa plate reader was used to measure
the absorbance at 630 nm. The difference in absorbance values
was recorded and was later used as an index of bacterial
S406 M. Noreen et al.growth. The results of antibacterial activity of newly synthe-
sized compounds are outlined in the Tables 5–7.
Following formula was used to determine Percentage
inhibition.
Percentage Inhibition¼O:D:ofpositive controlO:D:of sample100
O:D:of positive control2.7.1. 5-Phenylthiophene-2-sulfonamide (3a)
M.P. 183–186 C; 1H-NMR (400 MHz, CDCl3 + CD3OD):
d= 7.50–7.10 (m, 5H-Ar, 2H-Thiophene), 7.49 (s, 2H-NH2).
13C NMR (100 MHz, CDCl3 + CD3OD): d= 127.1 128.0,
128.9, 129.5, 130.0, 132.0, 135.1, 139.5; EIMS (m/z, +ion
mode): 239.00 [M]+; [M–NH2–C6H6]
+ = 147. Anal
calcd for C10H9NO2S2: C, 50.19; H, 3.79; N, 5.85; O,
13.37; S, 26.80. found: C, 50.25; H, 3.92; N, 5.98; O,
13.80; S, 26.98.
2.7.2. 5-(3-cyno-5-(triﬂuoromethyl)phenyl)thiophene-2-
sulfonamide (3b)
M.P. 155–158 C; 1H-NMR (400 MHz, CDCl3): d 8.06–7.0 (m,
3H-Ar, 2H-Thiophene), 7.51 (s, 2H, NH2)
a. 13C-NMR
(100 MHz, CDCl3 + CD3OD): d= 114.1, 119.1, 124.0,
127.1, 128.1, 128.7, 129.2, 130.9, 132.8, 134.9, 135.1, 139.2;
EIMS (m/z, + ion mode): 331.99 [M]+ ; [M–CF3–
CN]+ = 240.1 ; [M–O2]
+ = 301.08; [M - NH2]
+ = 317.08.
Anal calcd for C12H7N2F3O2S2: C, 43.37; H, 2.12; N, 8.43;
O, 9.63; S, 19.30. found: C, 43.50; H, 2.92; N, 8.98; O, 9.80;
S, 19.62.
2.7.3. 5-(3,5-bis(triﬂuoromethyl)phenyl)thiophene-2-
sulfonamide (3c)
M.P. 147–150 C; 1H-NMR (400 MHz, CDCl3): d 7.9–7.10 (m,
3H-Ar, 2H-Thiophene), 7.9 (s, 2H-NH2).
13C-NMR
(100 MHz, CDCl3 + CD3OD): d= 123.3, 125.1, 127.3,
129.2, 130.4, 133.2, 134.6, 136.4, 139.8; EIMS (m/z, +ion
mode): 375.00 [M]+. Anal calcd for C12H7NF6O2S2: C,
38.40; H, 1.88; N, 3.73; O, 8.53; S, 17.09. found: C, 39.00;
H, 1.92; N, 3.79; O, 8.61; S, 17.12.
2.7.4. 50-chloro-2,20-bithiophene-5-sulfonamide (3d)
M.P. 152–153 C;1H-NMR (400 MHz, CDCl3): d 7.67–7.11 (m
3H-Thiophene), 7.52 (s, 2H-NH2), 7.1 (d, J= 4,1H-thio-
phene). 13C NMR(100 MHz, CDCl3 + CD3OD):
d= 112.5,127.9,128.6,129.4,130.6,132.9,137.1,138.5; EIMS
(m/z, ion mode): 278.01 [M] ; [M–NH2]= 264; [M–
O2]
= 242.08. Anal calcd for C8H6NClO2S3: C, 34.34; H,
2.16; N, 5.01; O, 11.44; S, 34.38. found: C, 34.42; H, 2.20;
N, 5.34; O, 11.48; S, 34.42.
2.7.5. 50-methyl-2,20-bithiophene-5-sulfonamide (3e)
M.P. 154–156 C; 1H-NMR (400 MHz, CDCl3): d 7.73–7.09
(m, 3H-Thiophene), 7.51 (s, 2H-NH2), 7.0 (d, J= 4.2, 1H-Thi-
ophene), 2.40 (s, 3H, CH3).
13C-NMR (100 MHz, CDCl3 +
CD3OD): d= 16.1,125.5,127.9,128.4,129.2,133.2,137.6,137.1,
139.3; EIMS (m/z, +ion mode): 260.0 [M]+ ; [M–NH2–
SO2]
+ = 180.01; [M–O2]
+ = 226.0. Anal calcd for C9H9NO2-
S3: C, 41.68; H, 3.50; N, 5.40; O, 12.34; S, 37.09. found: C,
41.72; H, 3.58; N, 5.48; O, 12.40; S, 37.10.2.7.6. 5-p-tolylthiophene-2-sulfonamide (3f)
M.P. 144–147 C;1H-NMR (400 MHz, CDCl3): d 7.68–7.11
(m, 4H-Ar, 2H-Thiophene), 7.49 (s, 2H,NH2), 2.36 (s, 3H,
CH3).
13C-NMR (100 MHz, CDCl3 + CD3OD): d= 29.6,
127.4, 127.5, 128.1, 130.3, 132.4, 134.2, 134.1, 139.0; EIMS
(m/z, +ion mode): 254.25 [M] ; [M–CH3–SO2]
= 175.05.
Anal calcd for C11H11NO2S2: C, 52.15; H, 4.38; N, 5.53; O,
12.63; S, 25.31. found: C, 52.24; H, 4.42; N, 5.58; O, 12.72;
S, 25.38.
2.7.7. 5-(4-methoxyphenyl)thiophene-2-sulfonamide (3g)
M.P. 145.2–146 C;1H-NMR (400 MHz, CDCl3): d 7.6–6.9 (m,
4H-Ar, 2H-Thiophene), 7.49 (s, 2H,NH2), 3.82(s, 3H,OCH3).
13C-NMR (100 MHz, CDCl3 + CD3OD): d= 55.4, 114.9,
127.9, 128.1, 129.0, 130.1, 135.0, 139.1, 158.0; EIMS (m/z,
+ion mode): 270.00 [M]+; [M–NH2–SO2]
+ = 190.05; [M–
OCH3]+ = 240.17; [M–Benzene]+ = 190.00. Anal calcd for
C11H11NO3S2: C, 49.05; H, 4.12; N, 5.20; O, 17.82; S, 23.81.
found: C, 50.02; H, 4.18; N, 5.26; O, 17.88; S, 23.88.
2.7.8. 5-(4-chlorophenyl)thiophene-2-sulfonamide (3h)
M.P. 131.8–133.4 C; 1H-NMR (400 MHz, CDCl3): d 7.63–7.0
(m, 4H-Ar, 2H-Thiophene), 7.51 (s, 2H, NH2).
13C-NMR
(100 MHz, CDCl3 + CD3OD): d= 128.1, 129.2, 130.1,
131.4, 132.0, 133.4, 133.2, 139.0; EIMS (m/z, ion mode):
272.08 [M]; [M–SO2–NH2]
= 192.92; [M–Cl–Ben-
zene]= 161.17. Anal calcd for C10H8NClO2S2: C, 43.87; H,
2.95; N, 5.12; O, 11.69; S, 23.43. found: C, 43.92; H, 2.98;
N, 5.20; O, 11.80; S, 23.48.
2.7.9. 5-(3,4-dichlorophenyl)thiophene-2-sulfonamide (3i)
M.P. 123–124.7 C; 1H-NMR (400 MHz, CDCl3): d 7.70–7.0
(m, 3H-Ar, 2H-Thiophene), 7.51 (s, 2H, NH2).
13C-NMR
(100 MHz, CDCl3 + CD3OD): d= 127.0, 128.2, 129.5,
129.7, 133.1, 133.6, 134.0, 135.1, 139.2; EIMS (m/z, +ion
mode): 308.17 [M]+; [M–NH2]
+ = 293.0; [M–NH2–
SO2]
+ = 230.00; [M–SO2]
+ = 244.9; [M–NH2–
2Cl]+ = 224.00. Anal calcd for C10H7NCl2O2S2: C, 38.97;
H, 2.29; N, 4.54; O, 10.38; S, 20.18. found: C, 39.00; H,
2.32; N, 4.60; O, 10.44; S, 20.22.
2.7.10. 5-(3,5-dimethylphenyl)thiophene-2-sulfonamide (3j)
M.P. 138–140 C; 1H-NMR (400 MHz, CDCl3): d 7.67–6.90
(m, 3H-Ar, 2H-Thiophene), 7.51 (s, 2H,NH2), 2.35 (s,
3H,2CH3).
13C-NMR (100 MHz, CDCl3 + CD3OD):
d= 22.1, 127.0, 127.9, 129.9, 131.0, 131.6, 134.2, 139.0,
139.3; EIMS (m/z, +ion mode): 268.08 [M]+; [M–NH2–
SO2]
+ = 188.08. Anal calcd for C12H13NO2S2: C, 53.91; H,
4.90; N, 5.24; O, 11.97; S, 23.99. found: C, 54.02; H, 4.96;
N, 5.32; O, 12.00; S, 24.12.
2.7.11. 5-(4-chloro-3-ﬂuorophenyl)thiophene-2-sulfonamide
(3k)
M.P. 144–146 C; 1H-NMR (400 MHz, CDCl3): d 7.68–7.0 (m,
3H-Ar, 2H-Thiophene), 7.52 (s, 2H,NH2).
13C-NMR
(100 MHz, CDCl3 + CD3OD): d= 118.1, 121.0, 125.2,
127.1, 130.1, 131.2, 132.1, 134.2, 139.1, 164.0; EIMS (m/z,
+ion mode): 292.08 [M]+; [M–NH2–SO2]
+ = 212.08; [M–
F]+ = 274.92; [M–Cl]+ = 259.1. Anal calcd for C10H7-
Synthesis of thiophene sulfonamide derivatives via Suzuki cross coupling reactions S407NFClO2S2: C, 41.17; H, 2.42; N, 4.80; O, 10.97; S, 21.98.
found: C, 41.22; H, 2.52; N, 4.90; O, 11.00; S, 22.08.
2.7.12. N-(5-Bromothiophne-2-ylsulfonyl)acetamide (4)
M.P. 118–120 C; 1H-NMR (400 MHz, CDCl3): d 8.44 (s, 1H,
NH), 7.62 (d, J= 4.4, 1H-Thiophene), 7.09 (d, J= 4, 1H-Thi-
ophene), 2.12 (s, 3H, CH3),
13C NMR (100 MHz, CDCl3 +
CD3OD): d= 23.6, 122.2, 130.2, 135.4, 174.2; EIMS (m/z,
+ion mode): 284.00 [M]+; 282.00; [M–NH and Acetyl frag-
ment]+ = 226; [M–SO2 and Acetyl fragment]
+ = 178. Anal
calcd for C6H6NBrO3S2: C, 25.36; H, 2.13; N, 4.93; O,
16.89; S, 22.57. found: C, 25.46; H, 2.52; N, 5.12; O, 16.92;
S, 22.66.
3. Results and discussion
3.1. Synthesis
Herein, we describe the application of Suzuki cross coupling
reactions [22] to synthesize thiophene sulfonamide derivatives.
To the best of our knowledge, Suzuki cross coupling reactions
of 5-bromothiophene-2-sulfonamide have not been explored so
far, except for the coupling of phenyl boronic acid with 5-bro-
mothiophene-2-sulfonamide [4]. In the current experiments,
Pd(PPh3)4 was used as a catalyst, while K3PO4was used as a
base. The reactions were carried out at 95 C, and moderate
to excellent yields of the desired products were obtained under
these conditions. 5-Bromothiophene-2-sulfonamide (2) was
prepared by the reaction of 2-bromothiophene with chlorosul-
fonic acid, followed by the addition of aqueous ammonia
according to the previously reported method [31]. The Suzuki
reaction of 2 (0.704 mmol) with different aryl boronic acids
and boronic esters (0.774 mmol) produced 5-arylthiophene-2-
sulfonamides (3a–k) in moderate to good yields (Scheme 1,
Table 1) [33]. The solvent showed a signiﬁcant effect on the
yield of the reaction. It was also observed that the relatively
high solubility of oxygen and halogen containing aryl boronic
acids in 1,4-dioxane (compared to toluene) results in greater
yields of the products in 1,4-dioxane. On the other hand, theS Br S SBr NH2
O
O
ClSO3H, CCl4
-25oC, 30 min
aq.NH31 2
S SBr
O
O
(CH
CH
60oC
40 min
4
Scheme 1 Synthesis of 5-Bromothiophene-2-sulfonamide (2) and 5-
Bromothiophene (12 mmol), Chlorosulfonic acid (40–60 mmol), solve
boronic acid pinacol esters (0.774 mmol), K3PO4 (1.409 mmol), Pd(P
Synthesis of 5-Bromothiophene-2-sulfonyl acetamide 4. Reagents and
Acetonitrile (5 mL).major beneﬁt of using toluene is its high boiling point that
makes it useful for several high temperature reactions. A num-
ber of different 5-Arylthiophene-2-sulfonamides (3a–e)
(Table 1) were synthesized by using various aryl boronic esters,
while, the other types of thiophene derivatives [3f–k (Table 1)]
were synthesized by using arylboronic acids. It is important to
note that the aryl boronic esters and acids did not inﬂuence the
yield of 3a–k compounds.
Different derivatives of 5-bromothiophene-2-sulfonamide
were synthesized by Scheme 1 and the desired compounds
(3a–3k) were obtained in moderate to good yields. It was
observed that the products were synthesized in better yields
when 1,4-dioxane was used as the solvent (entries 1–7). Using
toluene as solvent, only moderate yields were obtained. The
other experimental conditions such as temperature, nature of
solvent and the water content also showed a great inﬂuence
on the ﬁnal yield of the product. The optimum solvent/water
ratio is found to be 4:1 (solvent/water), as previously reported
by [15].
3.2. Pharmacology
3.2.1. Urease inhibition activity
The chemical nature of 5-bromothiophene-2-sulfonamide
encouraged us to study the antiurease activities of our newly
synthesized compounds. An insight understanding about using
these compounds as urease inhibitors via enzyme catalyzed
mechanism can be established from the report of [34]. An ini-
tial screen of these compounds for their potential application
as urease inhibitor suggests that these compounds can be cat-
egorized into the following two groups;
 Group 1: Relatively less reactive group (compounds 3a, 3c–
f and 4).
 Group 2: Relatively more reactive group (compounds 3b
and 3g–k).
The urease inhibition activity (IC50) values were measured
for all compounds. Thiourea was used as control having theS SAr NH2
O
O
Aryl Boronic acids
and esters, K3PO4
Pd(PPh3)4, 
90oC, 30 h 3a-k
NH
O
3CO)2O
3CN/H2O
arylthiophene sulfonamide (3a–k). Reagents and conditions: (i) 1
nt (CCl4,6 ml); (ii) 2 (0.704 mmol), Aryl boronic acids and Aryl
Ph3)4 (5 mol %), solvent/H2O (4:1), (see Table 1), 95 C, 30 h.
conditions: (i): 2 (0.002 mmol), Acetic anhydride (0.0031 mmol),
Table 1 Synthesis of 5-arylthiophene-2-sulfonamide (3a–k).
Entry Aryl boronic acids and esters Product Solvent/H2O(4:1) Yield%
1 C6H4B(OR)2
SS
H2N
3a
O
O
Toluene 67
2 C6H4B(OR)2
SS
H2N
3a
O
O
Dioxane 78
3 3-CF3,5-CN,C6H3B(OR)2
SSO
O
H2N CN
CF33b
Dioxane 68
4 3,5- CF3-C6H3 B(OR)2
SSO
O
H2N CF3
CF33c
Dioxane 55
5 5-Cl,2-Thienyl B(OR)2
SSO
O
H2N
S Cl
3d
Dioxane 40
6 5-Me,2-Thienyl B(OR)2
SSO
O
H2N
S CH33e
Dioxane 67
7 4-Me-C6H4 B(OH)2
SSO
O
H2N
CH3
3f
Toluene 44
8 4-MeO-C6H4 B(OH)2
SSO
O
H2N
OCH3
3g
Dioxane 62
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Table 2 Urease inhibition data of 5-arylthiophene-2-sulfonamide based compounds [(3a), (3c–3f) and (4)].
Compounds Percentage activity at 25 lg/mL Percentage activity at 50 lg/mL Percentage activity at 250 lg/mL IC50 lg/mL
3a 37.11 ± 0.001 93.5 ± 0.0007 98 ± 0.007 30.8 ± 0.3
3c 13 ± 0.007 37.11 ± 0.001 76 ± 0.01 116 ± 1.12
3d 33 ± 0.05 64.9 ± 0.007 92 ± 0.005 38.4 ± 0.4
3e 19 ± 0.01 29.6 ± 0.006 54 ± 0.004 218 ± 2.1
3f 11 ± 0.01 22.3 ± 0.0007 56 ± 0.007 214 ± 1.98
4 18 ± 0.0007 36.3 ± 0.01 70 ± 0.01 132 ± 2.21
Standard (thiourea) 24 ± 0.002 60 ± 0.032 95 ± 0.09 43 ± 0.4
Table 1 (continued)
Entry Aryl boronic acids and esters Product Solvent/H2O(4:1) Yield%
9 4-Cl-C6H4 B(OH)2
SSO
O
H2N
Cl
3h
Dioxane 63
10 3,4-Cl2-C6H3 B(OH)2
SSO
O
H2N
Cl
Cl
3i
Dioxane 61
11 3,5-Me-C6H3 B(OH)2
SSO
O
H2N CH3
CH33j
Dioxane 62
12 3-F,4-Cl-C6H3 B(OH)2
SSO
O
H2N
Cl
F
3k
Dioxane 55
[a] isolated yield conditions: (95 C, 30 h).
Synthesis of thiophene sulfonamide derivatives via Suzuki cross coupling reactions S409percentage activities 24 ± 0.002, 60 ± 0.032, 95 ± 0.09 for
25, 50 and 250 lg/mL concentrations respectively. The IC50
value of thiourea was found to be 43 lg/L (Table 2). Similarly,
Table 3 shows that the thiourea percentage urease inhibition
activity for concentrations 15, 25 and 50 lg/mL was
34 ± 0.004, 51 ± 0.005 and 72 ± 0.005 respectively, whereas
the IC50 value was found to be 24.4 lg/mL. The compounds
having such functional groups can bind with active sites of
enzyme, which therefore impede the hydrolysis of enzyme
[32]. On the basis of these ﬁndings, we examined the antiurease
activity of these synthesized compounds, where almost all
compounds showed moderate to high urease enzyme inhibition
activity. Two sets of compounds were investigated for the ure-
ase inhibition assay with different concentrations. Compound5-Phenylthiophene-2-sulfonamide (3a) showed excellent urease
inhibition activity at 50 lg/mL concentration with percentage
inhibition activity 93.5 ± 0.0007. Similarly, compound 5-
(3-cyno-5-(triﬂouromethyl)phenyl)thiophene-2-sulfonamide
(3d) also showed the highest percentage inhibition 33 ± 0.05 at
25 lg/mL concentration along with IC50 value 38.4 lg/mL.
The highest antiurease activity of this compound might be
due to the presence of one more thiophene ring attachments.
At concentration 50 lg/mL, compound 5-(3,5-bis(triﬂou-
romethyl)phenyl)thiophene-2-sulfonamide(3c), was found a bet-
ter inhibitor displaying the percentage inhibition value
37.11 ± 0.04. Antiurease activities of 50-methyl-2,20-bithioph-
ene-5-sulfonamide(3e) and 5-p-tolylthiophene-2-sulfonamide (3f)
were also investigated at 250 lg/mL concentration, and their
Table 3 Urease inhibition data of 5-arylthiophene-2-sulfonamide based compounds [(3b), (3g–3k)].
Compounds Percentage activity at 15 lg/mL Percentage activity at 25 lg/mL Percentage activity at 50 lg/mL IC50 lg/mL
3b 28 ± 0.005 51 ± 0.001 80.05 ± 0.007 24.5 ± 0.21
3g 34 ± 0.001 55 ± 0.002 88.30 ± 0.004 22.6 ± 0.22
3h 33 ± 0.006 51 ± 0.001 80.43 ± 0.006 24.4 ± 0.23
3i 32 ± 0.03 56 ± 0.004 86.10 ± 0.005 22.5 ± 0.19
3j 22 ± 0.05 53 ± 0.005 83.34 ± 0.002 24 ± 0.18
3k 31 ± 0.006 50 ± 0.001 79.56 ± 0.002 23.6 ± 0.21
Standard (thiourea) 34 ± 0.004 51 ± 0.005 72 ± 0.005 24.4 ± 0.28
Figure 2 Urease percentage inhibition activity values at lg/mL.
S410 M. Noreen et al.IC50 values were found to be 218 lg/mL and 214 lg/mL with
percentage inhibition activities 54 ± 0.004 and 56 ± 0.007,
respectively (Table 2). Compounds 5-(3,4-dichlorophenyl)thio-
phene-2-sulfonamide (3i) and 5-(4-methoxyphenyl)thiophene-2-
sulfonamide (3g) were found to be the most effective antiurease
inhibitors at 50 lg/mL concentration and displayed the per-
centage activities 86.1 ± 0.005 and 88.30 ± 0.004 with IC50
values of 22.5 and 22.6 lg/mL, respectively. Moreover, com-
pounds 5-(4-chloro-3-ﬂourophenyl)thiophene-2-sulfonamide
(3k) and 5-(3,5-dimethylphenyl)thiophene-2-sulfonamide (3j)
containing chloro, ﬂouro and methyl moieties present on the
thiophene substituted phenyl rings were also found to be efﬁ-
cient urease inhibitors with percentage inhibition values
79.56 ± 0.002 and 22 ± 0.05. In addition, compound 5-(4-
chlorophenyl)thiophene-2-sulfonamide (3h) exhibited antiurease
activity with the percentage inhibition value 80.43 ± 0.006,
and IC50 value 24.4 lg/mL at 50 lg/mL concentration. In
the same way, compound 5-(3-cyano-5-(triﬂourometh-
yl)phenyl)thiophene-2-sulfonamide (3b) also facile inhibitory
response against urease enzyme with percentage inhibition
value 80.05 ± 0.007 along with IC50 value of 24.5 lg/mL
at 50 lg/mL concentration (Table 3). Some of the newly as-
synthesized compounds showed relatively higher antiurease
activity than others that showed moderate urease inhibition
activities. It was also noted that the electron withdrawing func-
tional groups present on the benzene ring have negative effect
of the inhibitor activity of these compounds against urease
enzyme, while, in contrast, the electron donating functional
groups present on the benzene ring led to the occurrence of
high inhibitor activity against urease enzyme. Moreover, the
electron withdrawing groups also cause a decrease in the metalFigure 1 Urease percentage inhibchelating activity and vice versa. Removal/chelation of Ni+2
ion will result in inactivation of the enzyme. Therefore, the
changes in urease inhibitory activity can be ascribed to the
changes in the electronic environments and the position of
functional groups in the series of compounds 3a–3k and com-
pound 4 (Figs. 1 and 2).
3.2.2. Hemolytic activity
Compared with the positive control triton X-100 standard;
compounds 3a–c, 3f and 3i showed moderate hemolytic activ-
ity, whereas compounds 3d, 3g–h and 3j–k exhibited the high-
est toxicity effects. Compound 3h exhibited highest % lysis ofition activity values at lg/mL.
Table 4 Hemolytic activity data of 5-
arylthiophene-2-sulfonamide based
compounds [(3a–3k) and (4)].
Compounds % lysis of RBC
3a 4.387 ± 0.115
3b 10.86 ± 0.174
3c 2.602 ± 0.164
3d 20.75 ± 0.164
3e 4.613 ± 0.749
3f 5.907 ± 0.115
3g 27.15 ± 0.339
3h 37.663 ± 0.115
3i 18.303 ± 0.329
3j 29.12 ± 0.223
3k 34.477 ± 0.380
4 14.605 ± 0.242
Triton · 100 99.783 ± 0.912
Figure 3 Hemolytic activity graph.
Table 5 Antibacterial activities (100 lg) of 5-arylthiophene-2-sulfon
Compounds % Activity at 100 lg
Bacillus Subtilis E coli Staphylococcu
3a 22 ± 0.019 12 ± 0.01 20.17 ± 0.02
3c 20 ± 0.002 25 ± 0.04 17.00 ± 0.004
3d 20 ± 0.002 20 ± 0.002 13.8 ± 0.004
3e 19 ± 0.007 12 ± 0.001 19.86 ± 0.001
3f 14 ± 0.015 15 ± 0.013 13.37 ± 0.000
4 30 ± 0.014 31 ± 0.002 31.18 ± 0.01
Streptomycin 60 ± 0.001 60 ± 0.001 60 ± 0.001
Table 6 Antibacterial activities (300 lg) of 5-arylthiophene-2-sulfon
Compounds % Activity at 300 lg
Bacillus Subtilis E. coli Staphylococc
3a 37 ± 0.114 35 ± 0.144 29.57 ± 0.00
3c 31 ± 0.07 41 ± 0.07 35.29 ± 0.00
3d 23.1 ± 0.000 24 ± 0.03 28.11 ± 0.00
3e 24.5 ± 0.000 25 ± 0.000 28.74 ± 0.00
3f 26.3 ± 0.000 30 ± 0.013 24.8 ± 0.00
4 41 ± 0.002 41 ± 0.002 45.58 ± 0.00
Streptomycin 83 ± 0.06 83 ± 0.06 83 ± 0.06
Synthesis of thiophene sulfonamide derivatives via Suzuki cross coupling reactions S411RBCs (37.663 ± 0.115) against triton X-100. Similarly, com-
pound 3k also showed extravagant hemolytic activity value
34.477 ± 0.380 due to the presence of electron withdrawing
F and Cl moieties present on the phenyl ring.
Table 4 shows that compound 5-(3,4-dichlorophenyl)thio-
phene-2-sulfonamide (3i), showed moderate hemolytic activity
value 18.303 ± 0.329, probably due to the presence of the
Cl group at meta and para positions in the aromatic phenyl
ring. The data from Table 4 also shows that compounds 3e
and 3f exhibited low toxicity effect with % lysis values of
RBC 4.613 ± 0.749 and 5.907 ± 0.115, respectively. On
the other hand, compound 3j showed a higher toxicity value
29.12 ± 0.223. This might be due to the presence of two
CH3 groups. Molongi et al. [23] reported that the anticancer
activity is usually enhanced by the presence of electron releas-
ing groups [23]. Therefore, the presence of two CH3 groups
in compound 3j could be the possible cause of the highest %
lysis of RBCs when compared with compound 3f having one
CH3 group. In view of the observed differences in the % lysis
of RBC values, it is suggested that the electron withdrawing
and electron donating nature of the attached groups have an
inﬂuence on the hemolytic activity of the compounds. More-
over, the position of functional groups also has an impact on
the hemolytic activity as can be seen from the results. Ding
and co-workers [9] reported that the compounds having the
Cl functional group at benzene ring exhibited better and higher
hemolytic activities than the compounds having H-atom or
OCH3 substitution at the same position [9]. In the present
study, we observed that compounds 3b–3c with CF3 and CN
moieties on the benzene ring show less hemolytic activities
10.86 ± 0.174 and 2.602 ± 0.164, respectively. Overall, it is
concluded that the presence of electron withdrawing groups
promote hemolytic activity, while, the position of functional
groups also contributes toward the hemolytic activity of all
newly synthesized sulfonamide series of compounds (3a–k) inamide (3a, 3c–f) and (4).
s Shigella Salmonella typhae Pseudomonas
31.1 ± 0.009 32.51 ± 0.006 32.06 ± 0.004
45.3 ± 0.005 37.82 ± 0.007 30.93 ± 0.002
32.02 ± 0.000 34.07 ± 0.015 32.5 ± 0.014
38.33 ± 0.0007 48.55 ± 0.014 35.05 ± 0.004
7 26.86 ± 0.004 41.44 ± 0.002 28.18 ± 0.003
43.62 ± 0.010 31.64 ± 0.0007 35.0 ± 0.014
60 ± 0.001 60 ± 0.001 60 ± 0.001
amide (3a, 3c–f) and (4).
us Shigella Salmonella typhae Pseudomonas
07 52.94 ± 0.001 40.2 ± 0.016 38.4 ± 0.003
05 44.98 ± 0.00 36.2 ± 0.006 40.64 ± 0.03
07 53.80 ± 0.00 28.33 ± 0.009 42.2 ± 0.024
07 49.30 ± 0.023 33.58 ± 0.007 41.86 ± 0.043
1 42.67 ± 0.00 29.15 ± 0.001 38.14 ± 0.004
07 48.73 ± 0.04 42.49 ± 0.002 40.93 ± 0.008
83 ± 0.06 83 ± 0.06 86 ± 0.06
Table 7 Antibacterial activities (1000 lg) of 5-arylthiophene-2-sulfonamide (3a, 3c–f) and (4).
Compounds % Activity at 1000 lg
Bacillus Subtilis E-Coli Staphylococcus Shigella Salmonella typhae Pseudomonas
3a 78 ± 0.007 71 ± 0.007 61 ± 0.006 75 ± 0.02 68 ± 0.0004 43 ± 0.5
3c 78 ± 0.00 76 ± 0.00 58 ± 0.001 67 ± 0.005 45 ± 0.006 56 ± 0.09
3d 20 ± 0.06 59 ± 0.06 53 ± 0.00032 64 ± 0.017 61 ± 0.004 55 ± 0.045
3e 34 ± 0.0021 54 ± 0.00 56 ± 0.004 67 ± 0.045 65 ± 0.001 64 ± 0.0012
3f 23 ± 0.002 63 ± 0.002 55 ± 0.005 76 ± 0.032 60 ± 0.00012 53 ± 0.004
4 70 ± 0.010 70 ± 0.010 70 ± 0.01 70 ± 0.005 65 ± 0.01 55 ± 0.004
Streptomycin 95 ± 0.004 95 ± 0.004 95 ± 0.004 95 ± 0.004 95 ± 0.004 95 ± 0.004
Figure 4 Antibacterial activity graph (100 lg).
S412 M. Noreen et al.the present study. These compounds [(3a–k) and (4)] showed
moderate to high % lysis of RBC and can be used as potential
anticancer agents (Fig. 3).
3.2.3. Bacteriological study
The sulfonamides display various biological activities includ-
ing carbonic anhydrase inhibition, insulin releasing, antimicro-
bial, antitumor and anti-inﬂammation activities [30]. Keche
and co-workers reported that the derivative of 1-Acetyl-3,5-
diaryl-4,5-dihydro(1H) pyrazole, having Br at ortho and CF3Figure 5 Antibacterial activity graph (300 lg).at para position of the benzene ring of terminal sulfonamide
is twice more efﬁcient against salmonella typhimurium and
staphylococcus aureus. While, the compound bearing Cl at
ortho position and CF3 at para position is 1.5-fold more
potent against Escherichia coli and Bacillus subtilis. This com-
pound is also found 1.3-fold more potent against staphylococ-
cus and salmonella typhimurium aureus as well [18]. The study
on the antibacterial activities of six newly as-synthesized deriv-
atives of thiophene sulfonamide was examined against two
gram positive bacteria and four gram negative bacteria. Table 7
shows that compound 3a (at 1000 lg concentration) exhibited
the highest % inhibition 78 ± 0.007, 71 ± 0.007 and
75 ± 0.02 against the Bacillus Subtilis, E-coli and Shigella,
respectively. The same compound at 100 and 300 lg concen-
trations showed moderate inhibition activities (Tables 5 and
6) against the same bacterial strains. Interestingly, in the case
of compound 3c (at 1000 lg concentration) bearing the CF3
group, magniﬁcent % antibacterial activities 78 ± 0.00,
76 ± 0.00, and 67 ± 0.005 were observed against Bacillus Sub-
tilis, E-coli and Shigella respectively. However, the compounds
3d, 3e and 3f (at 1000 lg concentration) showed moderate to
acceptable antibacterial activities (in order of 64.002 ± 0.00,
67 ± 0.045, and 76 ± 0.032, respectively) against Shigella (a
gram-negative bacterium), while the same compounds exhib-Figure 6 Antibacterial activity graph (300 lg).
Synthesis of thiophene sulfonamide derivatives via Suzuki cross coupling reactions S413ited poor inhibition activities against other gram-negative bac-
teria, (E. coli, Pseudomonas aeroginosa, Salmonella typhi) and
few gram-positive bacteria (Staphlococcusaureus and Bacillus
subtilis). It was interesting to note that the acetylated product
N-(5-Bromothiophne-2-ylsuelfonyl)acetamide (4) exhibited the
highest inhibition activities against both types of gram nega-
tive and gram positive bacteria at 1000 lg concentration.
Moreover, it was also observed that the electron donating
groups present at the phenyl ring of substituted thiophene sul-
fonamide had a positive impact to promote the antibacterial
activities of these newly synthesized thiophene based com-
pounds (Figs. 4–6).
4. Conclusions
In the current study, we report a facile route of Suzuki cross
coupling reaction to synthesize thiophene sulfonamide deriva-
tives (3a–3k).These newly synthesized compounds (3a–3k) and
compound 4 were identiﬁed for their purity and later investi-
gated for the urease enzyme inhibition and antibacterial and
hemolytic activities. Most of these thiophene sulfonamide
derivatives showed excellent activities with the exception of
some compounds that displayed moderate to low biological
activities. The detailed investigation in the present study
revealed that the electronic factors such as the nature and posi-
tion of various functional groups might be responsible for the
observed low anti-urease activities of some compounds. On the
other hand, the elevated anti-urease activity of compound 3d
might be due to the presence of second thiophene ring in the
compound. Moreover, the moderate antibacterial activity
observed in the case of compound 3e could be due to the pres-
ence of thiophene ring. Our investigation shows that the pres-
ence of F and Cl groups has a positive impact to enhance the
hemolytic activity of these newly synthesized thiophene sulfon-
amide derivatives. In such cases, the position of the functional
group showed a signiﬁcant effect on the hemolytic activity of
these compounds; an evidence of which can be seen in the case
of compound 3h. Though, few of the compounds showed anti-
bacterial activities, compounds 3e–f and 4 exhibited apprecia-
ble % antibacterial activity. Further biological studies need to
be done in order to fully explore these 2-bromothiophene
derivatives for the treatment of bacterial infections.Acknowledgments
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